CONSOLIDATED BALANCE SHEETS - USD ($)	Sep. 30, 2023	Sep. 30, 2022
Current assets:
Cash and cash equivalents	$ 7,151,800	$ 15,215,285
Accounts receivable, net of allowance of $75,000 and $330,853 at September 30, 2023 and 2022, respectively	255,502	3,067,544
Inventories	330,027	602,244
Prepaid expenses and other current assets	389,241	1,058,056
Total current assets	8,126,570	19,943,129
Property and equipment, net	838,270	2,222,988
Other assets:
Restricted cash	750,000
Intangible assets	2,698,975
Operating right of use asset	1,237,762
Deposits		98,997
Total assets	13,651,577	22,265,114
Current liabilities:
Accounts payable and accrued liabilities	2,270,388	3,621,751
Operating lease liability, current	498,598
Deferred revenue	76,435	563,557
Total current liabilities	2,845,421	4,185,308
Long term accrued liabilities	31,467	31,467
Deferred revenue, long term	194,000
Operating lease liability, long term	739,162
Deferred tax liability, net	684,115
Warrants classified as a liability	4,285,000	5,139,400
Total liabilities	8,779,165	9,356,175
Commitments and contingencies (Note J)
Applied DNA Sciences, Inc. stockholders' equity:
Preferred stock, par value $0.001 per share; 10,000,000 shares authorized; -0- shares issued and outstanding as of September 30 2023 and 2022, respectively	0	0
Common stock, par value $0.001 per share; 200,000,000 shares authorized as of September 30, 2023 and 2022, 13,658,520 and 12,908,520 shares issued and outstanding as of September 30, 2023 and 2022, respectively	13,659	12,909
Additional paid in capital	307,384,647	305,399,008
Accumulated deficit	(302,447,147)	(292,500,088)
Applied DNA Sciences, Inc. stockholders' equity	4,951,159	12,911,829
Noncontrolling interest	(78,747)	(2,890)
Total equity	4,872,412	12,908,939
Total liabilities and equity	13,651,577	22,265,114
Series A Preferred stock
Applied DNA Sciences, Inc. stockholders' equity:
Preferred stock, par value $0.001 per share; 10,000,000 shares authorized; -0- shares issued and outstanding as of September 30 2023 and 2022, respectively	0	0
Series B Preferred stock
Applied DNA Sciences, Inc. stockholders' equity:
Preferred stock, par value $0.001 per share; 10,000,000 shares authorized; -0- shares issued and outstanding as of September 30 2023 and 2022, respectively	$ 0	$ 0